Screen those who received controversial immunoglobulin for Aids, hepatitis B: MP

BY AJITH SIRIWARDANA AND YOHAN PERERA

Parliament, Nov. 30 (Daily Mirror)- Patients who had received the controversial substandard immunoglobulin medicine should be screened for Aids and hepatitis B, former State Health Minister Prof. Channa Jayasumana said today.

He told Parliament that controversial immunoglobulin medicine is a blood-based product and therefore could pose a serious health risk for those who had received it.

Prof. Jayasumana said a drastic increase in the spread of Aids could be observed in the country during the past few years where some 6,000 patients have been reported.

He said some 600 individuals who were infected with aids were identified in 2022.

The MP said one aids patients is reported for every 3,000 people in Sri Lanka.